A detailed analysis of the PIK3R1 copy number in serous ovarian cancer across TCGA revealed 68.4% heterozygous and 3.5% homozygous loss, respectively [23]. The gene discussed is PIK3R1; the disease is ovarian serous adenocarcinoma.